China Recombinant Vaccines Market Report & Forecast 2021-2027

List of Figures, Tables and Charts Available in China Recombinant Vaccines Market Report & Forecast 2021-2027

List of Tables
Table 1. Key Players of Recombinant Vaccines in China Market
Table 2. Top Recombinant Vaccines Players in China Market, Ranking by Revenue (2019)
Table 3. China Recombinant Vaccines Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Recombinant Vaccines Revenue Share by Companies, 2016-2021
Table 5. China Recombinant Vaccines Sales by Companies, (K Units), 2016-2021
Table 6. China Recombinant Vaccines Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Recombinant Vaccines Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Recombinant Vaccines Product Type
Table 9. List of Tier 1 Recombinant Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Recombinant Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Subunit Recombinant Vaccines
Table 12. Major Manufacturers of Attenuated Recombinant Vaccines
Table 13. By Type – China Recombinant Vaccines Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Recombinant Vaccines Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Recombinant Vaccines Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Recombinant Vaccines Sales (K Units), 2016-2021
Table 17. By Type - China Recombinant Vaccines Sales (K Units), 2022-2027
Table 18. By Application – China Recombinant Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Recombinant Vaccines Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Recombinant Vaccines Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Recombinant Vaccines Sales (K Units), 2016-2021
Table 22. By Application - China Recombinant Vaccines Sales (K Units), 2022-2027
Table 23. Merck & Co., Inc Corporation Information
Table 24. Merck & Co., Inc Description and Major Businesses
Table 25. Merck & Co., Inc Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Merck & Co., Inc Recombinant Vaccines Product
Table 27. Merck & Co., Inc Recent Developments
Table 28. Green Cross Corporation Corporation Information
Table 29. Green Cross Corporation Description and Major Businesses
Table 30. Green Cross Corporation Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Green Cross Corporation Recombinant Vaccines Product
Table 32. Green Cross Corporation Recent Developments
Table 33. Pfizer Inc. Corporation Information
Table 34. Pfizer Inc. Description and Major Businesses
Table 35. Pfizer Inc. Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Pfizer Inc. Recombinant Vaccines Product
Table 37. Pfizer Inc. Recent Developments
Table 38. Bayer AG Corporation Information
Table 39. Bayer AG Description and Major Businesses
Table 40. Bayer AG Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Bayer AG Recombinant Vaccines Product
Table 42. Bayer AG Recent Developments
Table 43. Sanofi S A. Corporation Information
Table 44. Sanofi S A. Description and Major Businesses
Table 45. Sanofi S A. Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Sanofi S A. Recombinant Vaccines Product
Table 47. Sanofi S A. Recent Developments
Table 48. Protein Science Corporation Corporation Information
Table 49. Protein Science Corporation Description and Major Businesses
Table 50. Protein Science Corporation Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Protein Science Corporation Recombinant Vaccines Product
Table 52. Protein Science Corporation Recent Developments
Table 53. GlaxoSmithKline Plc. Corporation Information
Table 54. GlaxoSmithKline Plc. Description and Major Businesses
Table 55. GlaxoSmithKline Plc. Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. GlaxoSmithKline Plc. Recombinant Vaccines Product
Table 57. GlaxoSmithKline Plc. Recent Developments
Table 58. Novartis AG Corporation Information
Table 59. Novartis AG Description and Major Businesses
Table 60. Novartis AG Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. Novartis AG Recombinant Vaccines Product
Table 62. Novartis AG Recent Developments
Table 63. Bharat Biotech Corporation Information
Table 64. Bharat Biotech Description and Major Businesses
Table 65. Bharat Biotech Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. Bharat Biotech Recombinant Vaccines Product
Table 67. Bharat Biotech Recent Developments
Table 68. Recombinant Vaccines Production Capacity (K Units) of Key Manufacturers in China Market, 2019-2021 (K Units)
Table 69. China Recombinant Vaccines Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Recombinant Vaccines Market Opportunities & Trends in China Market
Table 71. Recombinant Vaccines Market Drivers in China Market
Table 72. Recombinant Vaccines Market Restraints in China Market
Table 73. Recombinant Vaccines Raw Materials
Table 74. Recombinant Vaccines Raw Materials Suppliers in China Market
Table 75. Typical Recombinant Vaccines Downstream
Table 76. Recombinant Vaccines Downstream Clients in China Market
Table 77. Recombinant Vaccines Distributors and Sales Agents in China Market
List of Figures
Figure 1. Recombinant Vaccines Product Picture
Figure 2. Recombinant Vaccines Segment by Type
Figure 3. Recombinant Vaccines Segment by Application
Figure 4. China Recombinant Vaccines Market Overview: 2020
Figure 5. China Recombinant Vaccines Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Recombinant Vaccines Revenue, 2016-2027 (US$, Mn)
Figure 7. Recombinant Vaccines Sales in China Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Vaccines Revenue in 2020
Figure 9. Subunit Recombinant Vaccines Product Picture
Figure 10. Attenuated Recombinant Vaccines Product Picture
Figure 11. Vector Recombinant Vaccines Product Picture
Figure 12. By Type - China Recombinant Vaccines Sales Market Share, 2016-2027
Figure 13. By Type - China Recombinant Vaccines Revenue Market Share, 2016-2027
Figure 14. By Type - China Recombinant Vaccines Price (USD/Unit), 2016-2027
Figure 15. Recombinant Human Vaccines
Figure 16. Animal Recombinant Vaccines
Figure 17. By Application - China Recombinant Vaccines Sales Market Share, 2016-2027
Figure 18. By Application - China Recombinant Vaccines Revenue Market Share, 2016-2027
Figure 19. By Application - China Recombinant Vaccines Price (USD/Unit), 2016-2027
Figure 20. Merck & Co., Inc Recombinant Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Green Cross Corporation Recombinant Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Pfizer Inc. Recombinant Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Bayer AG Recombinant Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Sanofi S A. Recombinant Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Protein Science Corporation Recombinant Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. GlaxoSmithKline Plc. Recombinant Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Novartis AG Recombinant Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Bharat Biotech Recombinant Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. China Recombinant Vaccines Production Capacity (K Units), 2016-2027
Figure 30. Recombinant Vaccines Industry Value Chain
Figure 31. Marketing Channels

Keyplayers in China Recombinant Vaccines Market Report & Forecast 2021-2027

Merck & Co., Inc
Green Cross Corporation
Pfizer Inc.
Bayer AG
Sanofi S A.
Protein Science Corporation
GlaxoSmithKline Plc.
Novartis AG
Bharat Biotech